HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
about
Epigenetics in heart failure phenotypesEpigenetic associations in relation to cardiovascular prevention and therapeuticsHistone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.Epigenetic regulation of cardiac fibrosis.Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line.Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertensionMyofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZLoss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy.Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes.Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300.Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.Hypothesis: Role for ammonia neutralization in the prevention and reversal of heart failure.TRAF molecules in inflammation and inflammatory diseases.Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females.HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs.Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architectureFood Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart FailureThe Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart
P2860
Q26747565-BCFC841B-61D6-45AB-A8D5-0E9D64C1EE20Q26771428-38EE3180-CF27-4678-8C9D-D196D48FB45CQ37239770-2A6DCD11-9265-45EA-A708-86E6929FE54BQ37672722-FAF6B074-97DA-424A-858F-CA00E009F8F9Q38733315-3A0D7375-57E3-4BAD-A97B-62B99F2B2ACAQ38753861-B7E46797-88DF-436D-983A-AC398BF6F320Q38770298-A59DDF26-88B9-4C09-BF0A-CB1D60E903DBQ41642050-4CD9FB6D-D220-4479-88AB-19F6E0AB8EA0Q41741744-3A62B744-078E-4778-912A-F39BADDA373BQ47668907-BFAA413B-E825-4EAF-8A73-CFFB2465BA8DQ48666421-03CC2345-2AAE-40A9-BD0F-D665B86EA43FQ49738731-E77FF92C-C1D9-42B4-963E-A821D164E2AEQ50630504-C06C5852-8F2E-48E0-822C-D40A88C3C8D4Q52652520-A78714ED-4354-438C-A111-90A02762A3DDQ52661592-B993BEF4-C9F3-4B97-9DEE-FA7EA1BE1FA8Q54090659-B583FFD8-7A1A-4C23-B163-61E7680E162FQ55323751-624A136C-9B66-4146-9AE4-F883B00D3E9CQ58706055-4DB3CC62-730B-4696-B3AB-F3E876FEC00AQ58766782-F2213AA7-7D96-4326-A615-2379B95CCDE5Q60927794-60deb82f-4db4-87c0-bc90-508372c5b233
P2860
HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
HDAC inhibition attenuates car ...... deacetylation of target genes.
@ast
HDAC inhibition attenuates car ...... deacetylation of target genes.
@en
type
label
HDAC inhibition attenuates car ...... deacetylation of target genes.
@ast
HDAC inhibition attenuates car ...... deacetylation of target genes.
@en
prefLabel
HDAC inhibition attenuates car ...... deacetylation of target genes.
@ast
HDAC inhibition attenuates car ...... deacetylation of target genes.
@en
P2093
P2860
P50
P1433
P1476
HDAC inhibition attenuates car ...... deacetylation of target genes.
@en
P2093
Jenny Y Y Ooi
Natasha K Tuano
Xiao-Jun Du
Xiao-Ming Gao
P2860
P304
P356
10.1080/15592294.2015.1024406
P577
2015-05-05T00:00:00Z